top of page
Search

FDA Grants Breakthrough Therapy Designation for Lucentis in Diabetic Retinopathy

  • Marin Retina
  • Dec 16, 2014
  • 1 min read

December 15, 2014


Based on the phase 3 RISE/RIDE trials, which show meaningful improvements in diabetic retinopathy in Lucentis-treated patients compared to sham-treated patients over 2 years, the FDA has granted Lucentis breakthrough therapy designation.




 
 

 

Amitabh Bharadwaj, MD

Retina Specialists of Northern California​

​

1050 Northgate Drive, Suite 354         1320 Tara Hills Drive, Suite H

San Rafael, CA  94903                        Pinole, CA  94564

(415) 419-5450                                    (510) 724-1100

 

To Schedule An Appointment

           Call Today

           

c 2013 Retina Specialists of Northern California

c 2018 Retina Specialists of Northern California

bottom of page